Shopping Cart 0
Cart Subtotal
AED 0

Global Urological Cancer Drugs Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 10937

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 11671

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 21873

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 21873

Details

Snapshot

The global Urological Cancer Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Urological Cancer Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Xofigo (Radium Ra 223 Dichloride)

Jevtana (Cabazitaxel)

Inlyta (Axitinib)

Votrient (Pazopanib Hydrochloride)

Sutent (Sunitinib Malate)

Zytiga (Abiraterone Acetate)

Xtandi (Enzalutamide)

Opdivo (Nivolumab)

Provenge (Sipuleucel-T)

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Novartis

Pfizer

Johnson & Johnson

AstraZeneca

Astellas

Bristol-Myers Squibb

Abbott Laboratories

Celgene Corporation

Dendreon Corporation

Ferring Pharmaceuticals

GlaxoSmithKline

Indevus Pharmaceuticals Inc

Ipsen

Roche Healthcare

Sanofi S.A.

Tolmar Inc

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Prostate Cancer

Bladder Cancer

Kidney Cancer

Testicular Cancer

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Urological Cancer Drugs Industry

1.1.1 Overview

1.1.2 Development of Urological Cancer Drugs

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Urological Cancer Drugs Market by Type

3.1 By Type

3.1.1 Xofigo (Radium Ra 223 Dichloride)

3.1.2 Jevtana (Cabazitaxel)

3.1.3 Inlyta (Axitinib)

3.1.4 Votrient (Pazopanib Hydrochloride)

3.1.5 Sutent (Sunitinib Malate)

3.1.6 Zytiga (Abiraterone Acetate)

3.1.7 Xtandi (Enzalutamide)

3.1.8 Opdivo (Nivolumab)

3.1.9 Provenge (Sipuleucel-T)

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Urological Cancer Drugs Novartis (Company Profile, Sales Data etc.)

4.2 Pfizer (Company Profile, Sales Data etc.)

4.3 Johnson & Johnson (Company Profile, Sales Data etc.)

4.4 AstraZeneca (Company Profile, Sales Data etc.)

4.5 Astellas (Company Profile, Sales Data etc.)

4.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)

4.7 Abbott Laboratories (Company Profile, Sales Data etc.)

4.8 Celgene Corporation (Company Profile, Sales Data etc.)

4.9 Dendreon Corporation (Company Profile, Sales Data etc.)

4.10 Ferring Pharmaceuticals (Company Profile, Sales Data etc.)

4.11 GlaxoSmithKline (Company Profile, Sales Data etc.)

4.12 Indevus Pharmaceuticals Inc (Company Profile, Sales Data etc.)

4.13 Ipsen (Company Profile, Sales Data etc.)

4.14 Roche Healthcare (Company Profile, Sales Data etc.)

4.15 Sanofi S.A. (Company Profile, Sales Data etc.)

4.16 Tolmar Inc (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Prostate Cancer

6.1.2 Demand in Bladder Cancer

6.1.3 Demand in Kidney Cancer

6.1.4 Demand in Testicular Cancer

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Urological Cancer Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Urological Cancer Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Urological Cancer Drugs Market Concentration, in 2018

Figure Europe Urological Cancer Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Urological Cancer Drugs MMarket Concentration, in 2018

Figure South America Urological Cancer Drugs Market Concentration, in 2018

Figure Middle East & Africa Urological Cancer Drugs Market Concentration, in 2018

Figure Urological Cancer Drugs Demand in Prostate Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Prostate Cancer, 2013-2018, in Volume

Figure Urological Cancer Drugs Demand in Bladder Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Bladder Cancer, 2013-2018, in Volume

Figure Urological Cancer Drugs Demand in Kidney Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Kidney Cancer, 2013-2018, in Volume

Figure Urological Cancer Drugs Demand in Testicular Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Testicular Cancer, 2013-2018, in Volume

Figure North America Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Urological Cancer Drugs

Table Application Segment of Urological Cancer Drugs

Table Global Urological Cancer Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Xofigo (Radium Ra 223 Dichloride)

Table Major Company List of Jevtana (Cabazitaxel)

Table Major Company List of Inlyta (Axitinib)

Table Major Company List of Votrient (Pazopanib Hydrochloride)

Table Major Company List of Sutent (Sunitinib Malate)

Table Major Company List of Zytiga (Abiraterone Acetate)

Table Major Company List of Xtandi (Enzalutamide)

Table Major Company List of Opdivo (Nivolumab)

Table Major Company List of Provenge (Sipuleucel-T)

Table Global Urological Cancer Drugs Market 2013-2018, by Type, in USD Million

Table Global Urological Cancer Drugs Market 2013-2018, by Type, in Volume

Table Global Urological Cancer Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Urological Cancer Drugs Market Forecast 2019-2024, by Type, in Volume

Table Novartis Overview List

Table Urological Cancer Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Urological Cancer Drugs Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Urological Cancer Drugs Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Urological Cancer Drugs Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Astellas Overview List

Table Urological Cancer Drugs Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Urological Cancer Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Abbott Laboratories Overview List

Table Urological Cancer Drugs Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Urological Cancer Drugs Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dendreon Corporation Overview List

Table Urological Cancer Drugs Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ferring Pharmaceuticals Overview List

Table Urological Cancer Drugs Business Operation of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Urological Cancer Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Indevus Pharmaceuticals Inc Overview List

Table Urological Cancer Drugs Business Operation of Indevus Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ipsen Overview List

Table Urological Cancer Drugs Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Healthcare Overview List

Table Urological Cancer Drugs Business Operation of Roche Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi S.A. Overview List

Table Urological Cancer Drugs Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Tolmar Inc Overview List

Table Urological Cancer Drugs Business Operation of Tolmar Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Urological Cancer Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Urological Cancer Drugs Sales Revenue Share, by Company, in USD Million

Table Global Urological Cancer Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Urological Cancer Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Urological Cancer Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Urological Cancer Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Urological Cancer Drugs Production 2013-2018, by Region, in USD Million

Table Urological Cancer Drugs Production 2013-2018, by Region, in Volume

Table Global Urological Cancer Drugs Market 2013-2018, by Region, in USD Million

Table Global Urological Cancer Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Urological Cancer Drugs Market 2013-2018, by Region, in Volume

Table Global Urological Cancer Drugs Market Share 2013-2018, by Region, in Volume

Table North America Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table South America Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Urological Cancer Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Urological Cancer Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Snapshot

The global Urological Cancer Drugs market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Urological Cancer Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Xofigo (Radium Ra 223 Dichloride)

Jevtana (Cabazitaxel)

Inlyta (Axitinib)

Votrient (Pazopanib Hydrochloride)

Sutent (Sunitinib Malate)

Zytiga (Abiraterone Acetate)

Xtandi (Enzalutamide)

Opdivo (Nivolumab)

Provenge (Sipuleucel-T)

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Novartis

Pfizer

Johnson & Johnson

AstraZeneca

Astellas

Bristol-Myers Squibb

Abbott Laboratories

Celgene Corporation

Dendreon Corporation

Ferring Pharmaceuticals

GlaxoSmithKline

Indevus Pharmaceuticals Inc

Ipsen

Roche Healthcare

Sanofi S.A.

Tolmar Inc

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Prostate Cancer

Bladder Cancer

Kidney Cancer

Testicular Cancer

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Urological Cancer Drugs Industry

1.1.1 Overview

1.1.2 Development of Urological Cancer Drugs

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Urological Cancer Drugs Market by Type

3.1 By Type

3.1.1 Xofigo (Radium Ra 223 Dichloride)

3.1.2 Jevtana (Cabazitaxel)

3.1.3 Inlyta (Axitinib)

3.1.4 Votrient (Pazopanib Hydrochloride)

3.1.5 Sutent (Sunitinib Malate)

3.1.6 Zytiga (Abiraterone Acetate)

3.1.7 Xtandi (Enzalutamide)

3.1.8 Opdivo (Nivolumab)

3.1.9 Provenge (Sipuleucel-T)

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Urological Cancer Drugs Novartis (Company Profile, Sales Data etc.)

4.2 Pfizer (Company Profile, Sales Data etc.)

4.3 Johnson & Johnson (Company Profile, Sales Data etc.)

4.4 AstraZeneca (Company Profile, Sales Data etc.)

4.5 Astellas (Company Profile, Sales Data etc.)

4.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)

4.7 Abbott Laboratories (Company Profile, Sales Data etc.)

4.8 Celgene Corporation (Company Profile, Sales Data etc.)

4.9 Dendreon Corporation (Company Profile, Sales Data etc.)

4.10 Ferring Pharmaceuticals (Company Profile, Sales Data etc.)

4.11 GlaxoSmithKline (Company Profile, Sales Data etc.)

4.12 Indevus Pharmaceuticals Inc (Company Profile, Sales Data etc.)

4.13 Ipsen (Company Profile, Sales Data etc.)

4.14 Roche Healthcare (Company Profile, Sales Data etc.)

4.15 Sanofi S.A. (Company Profile, Sales Data etc.)

4.16 Tolmar Inc (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Prostate Cancer

6.1.2 Demand in Bladder Cancer

6.1.3 Demand in Kidney Cancer

6.1.4 Demand in Testicular Cancer

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Urological Cancer Drugs Market Growth 2013-2018, by Type, in USD Million

Figure Global Urological Cancer Drugs Market Growth 2013-2018, by Type, in Volume

Figure North America Urological Cancer Drugs Market Concentration, in 2018

Figure Europe Urological Cancer Drugs Market Market Concentration, in 2018

Figure Asia-Pacific Urological Cancer Drugs MMarket Concentration, in 2018

Figure South America Urological Cancer Drugs Market Concentration, in 2018

Figure Middle East & Africa Urological Cancer Drugs Market Concentration, in 2018

Figure Urological Cancer Drugs Demand in Prostate Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Prostate Cancer, 2013-2018, in Volume

Figure Urological Cancer Drugs Demand in Bladder Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Bladder Cancer, 2013-2018, in Volume

Figure Urological Cancer Drugs Demand in Kidney Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Kidney Cancer, 2013-2018, in Volume

Figure Urological Cancer Drugs Demand in Testicular Cancer, 2013-2018, in USD Million

Figure Urological Cancer Drugs Demand in Testicular Cancer, 2013-2018, in Volume

Figure North America Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure North America Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Europe Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Europe Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure South America Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure South America Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Urological Cancer Drugs Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Urological Cancer Drugs Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Urological Cancer Drugs

Table Application Segment of Urological Cancer Drugs

Table Global Urological Cancer Drugs Market 2013-2024, by Application, in USD Million

Table Major Company List of Xofigo (Radium Ra 223 Dichloride)

Table Major Company List of Jevtana (Cabazitaxel)

Table Major Company List of Inlyta (Axitinib)

Table Major Company List of Votrient (Pazopanib Hydrochloride)

Table Major Company List of Sutent (Sunitinib Malate)

Table Major Company List of Zytiga (Abiraterone Acetate)

Table Major Company List of Xtandi (Enzalutamide)

Table Major Company List of Opdivo (Nivolumab)

Table Major Company List of Provenge (Sipuleucel-T)

Table Global Urological Cancer Drugs Market 2013-2018, by Type, in USD Million

Table Global Urological Cancer Drugs Market 2013-2018, by Type, in Volume

Table Global Urological Cancer Drugs Market Forecast 2019-2024, by Type, in USD Million

Table Global Urological Cancer Drugs Market Forecast 2019-2024, by Type, in Volume

Table Novartis Overview List

Table Urological Cancer Drugs Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Urological Cancer Drugs Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Urological Cancer Drugs Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Urological Cancer Drugs Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Astellas Overview List

Table Urological Cancer Drugs Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol-Myers Squibb Overview List

Table Urological Cancer Drugs Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Abbott Laboratories Overview List

Table Urological Cancer Drugs Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Urological Cancer Drugs Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dendreon Corporation Overview List

Table Urological Cancer Drugs Business Operation of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ferring Pharmaceuticals Overview List

Table Urological Cancer Drugs Business Operation of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Urological Cancer Drugs Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Indevus Pharmaceuticals Inc Overview List

Table Urological Cancer Drugs Business Operation of Indevus Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ipsen Overview List

Table Urological Cancer Drugs Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Healthcare Overview List

Table Urological Cancer Drugs Business Operation of Roche Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi S.A. Overview List

Table Urological Cancer Drugs Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Tolmar Inc Overview List

Table Urological Cancer Drugs Business Operation of Tolmar Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Urological Cancer Drugs Sales Revenue 2013-2018, by Company, in USD Million

Table Global Urological Cancer Drugs Sales Revenue Share, by Company, in USD Million

Table Global Urological Cancer Drugs Sales Volume 2013-2018, by Company, in Volume

Table Global Urological Cancer Drugs Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Urological Cancer Drugs Demand Forecast 2019-2024, by Application, in USD Million

Table Urological Cancer Drugs Demand Forecast 2019-2024, by Application, in Volume

Table Urological Cancer Drugs Production 2013-2018, by Region, in USD Million

Table Urological Cancer Drugs Production 2013-2018, by Region, in Volume

Table Global Urological Cancer Drugs Market 2013-2018, by Region, in USD Million

Table Global Urological Cancer Drugs Market Share 2013-2018, by Region, in USD Million

Table Global Urological Cancer Drugs Market 2013-2018, by Region, in Volume

Table Global Urological Cancer Drugs Market Share 2013-2018, by Region, in Volume

Table North America Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table North America Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Europe Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Europe Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table South America Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table South America Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Urological Cancer Drugs Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Urological Cancer Drugs Market Size 2013-2018, by Country, in Volume

Table Urological Cancer Drugs Market Forecast 2019-2024, by Region, in USD Million

Table Urological Cancer Drugs Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS